BridgeBio Pharma, Inc. (BBIO) - Net earnings per share (EPS TTM)

Symbol and logo of brand bridgebio.com (BBIO)

BridgeBio Pharma, Inc. (BBIO) is transitioning from laboratory research to full-scale commercialization as it expands its drug portfolio. This chart from the GURU.Markets platform illustrates the net income per share over the last 12 months, where the parameter has stabilized at -3.03. The "hub-and-spoke" model minimizes development risks, while the integration of ESG standards into genetics ensures the environmental sustainability and ethical production of medications.

BBIO (bridgebio.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for BridgeBio Pharma (BBIO)

- share price and expert price forecast:
Stock Quotes BridgeBio Pharma, Inc.|BBIO - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization BridgeBio Pharma|BBIO - Total Enterprise Value
- business book valuation details:
Book Value per Share BridgeBio|BBIO - Accounting Capitalization|Market Cap to Net Assets Ratio bridgebio.com|BBIO - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity BridgeBio Pharma, Inc.|BBIO - Long-Term Liabilities to Equity|Short-Term Debt to Capital BridgeBio Pharma Inc|BBIO - Aggregate Debt Obligations|Debts to Book Capitalization BridgeBio Pharma|BBIO - Company Long-Term Debts|Company Short-Term Debt BridgeBio|Quick Liquidity bridgebio.com
- net income and valuation multiples indicators:
BBIO - Net Income|Projected Future Earnings BridgeBio Pharma, Inc.|BBIO - P/E Multiple|Forward P/E Multiple BridgeBio|BBIO - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BridgeBio Pharma|BBIO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) BridgeBio|BBIO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth bridgebio.com|BBIO - Earnings per share growth this year|Earnings growth forecast for next year BridgeBio Pharma, Inc.
- sales volume and revenue information:
BBIO - Company Total Sales Volume|Projected Sales Volume BridgeBio Pharma, Inc.|BBIO - Price to Sales|Forward P/S Multiple BridgeBio Pharma
General company analysis:BridgeBio Pharma, Inc. (BBIO)
Mass-produced product of BridgeBio Pharma

To minimize investment risks, it is critical to track the real return of each stock via the total annual net income. For BridgeBio Pharma, Inc. (BBIO), which is establishing monopoly positions in the orphan drug sector, the trailing 12-month EPS reflects the efficiency of monetizing unique technologies. Analyzing this metric allows for an assessment of the actual earnings per share, determining the long-term cost of capital.

Competitors of BridgeBio Pharma, Inc. (BBIO)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp (UTHR)|BMRN (BioMarin Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BGM (BGM Group Corp)|Net earnings per share for the last 12 months COGT (Cogent Biosciences)|XERS (xerispharma.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Keros Therapeutics, Inc. KROS|ARCT (Arcturus Therapeutics Inc) - Earnings per one share for the last 12 months|Eton Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Pharma)|FULC: Net earnings per share (EPS TTM)|Abeona Therapeutics Inc. (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Mereo BioPharma Group|PLX: Earnings per share for the trailing year|Earnings per share for the last twelve months Pliant Therapeutics (PLRX)|Net earnings per share for the last 12 months appliedtherapeutics.com APLT|Net earnings per share (EPS TTM) RNTX (Rein Therapeutics Inc)|Net earnings per share (EPS TTM) Gelteq Ltd GELS|Aytu Therapeutics - Net earnings per share (EPS TTM)|CMMB: Earnings per share for the last twelve months|srxhealth.com (SRXH) - Earnings per share for the last twelve months|Polyrizon - Earnings per share for the trailing year|AEZS (Aeterna Zentaris Inc) - Net earnings per share (EPS TTM)|cyclotherapeutics.com (CYTH) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) INZY|Reneo Pharmaceuticals Inc. - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CSCI (Aeterna Zentaris)